Liminatus Pharma Warrants Overview
Liminatus Pharma Warrants Discounted Cash Flow
DCF Analysis for LIMNW.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.05
Current Fair Value
$-0.05
↓ 146.5% Downside
Overvalued by 146.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison